Berliner Boersenzeitung - WTO chief hails Covid vaccines IP compromise

EUR -
AED 4.325935
AFN 82.295246
ALL 97.926243
AMD 452.928874
ANG 2.108041
AOA 1080.157743
ARS 1450.537772
AUD 1.798908
AWG 2.12321
AZN 2.007149
BAM 1.955925
BBD 2.378252
BDT 144.489211
BGN 1.955925
BHD 0.443228
BIF 3509.023701
BMD 1.177925
BND 1.500096
BOB 8.139519
BRL 6.38271
BSD 1.177875
BTN 100.523408
BWP 15.600995
BYN 3.854646
BYR 23087.331819
BZD 2.365951
CAD 1.60298
CDF 3398.314319
CHF 0.935405
CLF 0.028538
CLP 1095.129815
CNY 8.440309
CNH 8.439249
COP 4689.39895
CRC 594.837921
CUC 1.177925
CUP 31.215015
CVE 110.27203
CZK 24.646321
DJF 209.743371
DKK 7.461454
DOP 70.494494
DZD 152.109697
EGP 58.022699
ERN 17.668876
ETB 163.469121
FJD 2.637615
FKP 0.862849
GBP 0.862601
GEL 3.204416
GGP 0.862849
GHS 12.190777
GIP 0.862849
GMD 84.22618
GNF 10215.651249
GTQ 9.056577
GYD 246.42571
HKD 9.24601
HNL 30.773962
HRK 7.536412
HTG 154.649859
HUF 399.203326
IDR 19062.0084
ILS 3.944853
IMP 0.862849
INR 100.708477
IQD 1542.998366
IRR 49620.09495
ISK 142.446936
JEP 0.862849
JMD 188.001985
JOD 0.835195
JPY 170.168995
KES 152.179701
KGS 103.010002
KHR 4732.301685
KMF 492.373101
KPW 1060.132584
KRW 1604.946949
KWD 0.359609
KYD 0.981663
KZT 611.718997
LAK 25381.61808
LBP 105536.527962
LKR 353.392529
LRD 236.165056
LSL 20.719221
LTL 3.478107
LVL 0.712516
LYD 6.344404
MAD 10.572174
MDL 19.841265
MGA 5300.337897
MKD 61.533923
MMK 2473.327031
MNT 4221.285995
MOP 9.523607
MRU 46.74898
MUR 52.948179
MVR 18.14445
MWK 2042.530211
MXN 21.945864
MYR 4.972067
MZN 75.340533
NAD 20.719221
NGN 1802.15516
NIO 43.342763
NOK 11.881146
NPR 160.837253
NZD 1.940089
OMR 0.452069
PAB 1.177875
PEN 4.176666
PGK 4.86531
PHP 66.570482
PKR 334.365716
PLN 4.244948
PYG 9386.598396
QAR 4.304974
RON 5.059075
RSD 117.187471
RUB 92.85592
RWF 1693.207942
SAR 4.415727
SBD 9.820272
SCR 16.592058
SDG 707.348348
SEK 11.264384
SGD 1.500092
SHP 0.925664
SLE 26.444855
SLL 24700.50455
SOS 673.142913
SRD 44.036774
STD 24380.6712
SVC 10.306657
SYP 15315.295503
SZL 20.70332
THB 38.118091
TJS 11.45473
TMT 4.134517
TND 3.431819
TOP 2.758823
TRY 46.91719
TTD 7.988509
TWD 34.086841
TZS 3109.79825
UAH 49.123132
UGX 4225.269361
USD 1.177925
UYU 47.273014
UZS 14790.942924
VES 128.951587
VND 30838.07893
VUV 139.499805
WST 3.053192
XAF 655.99882
XAG 0.031783
XAU 0.000353
XCD 3.183402
XDR 0.815852
XOF 655.99882
XPF 119.331742
YER 285.234989
ZAR 20.734144
ZMK 10602.74357
ZMW 28.533819
ZWL 379.291399
  • CMSC

    0.0900

    22.314

    +0.4%

  • CMSD

    0.0250

    22.285

    +0.11%

  • RBGPF

    0.0000

    69.04

    0%

  • SCS

    0.0400

    10.74

    +0.37%

  • RELX

    0.0300

    53

    +0.06%

  • RIO

    -0.1400

    59.33

    -0.24%

  • GSK

    0.1300

    41.45

    +0.31%

  • NGG

    0.2700

    71.48

    +0.38%

  • BP

    0.1750

    30.4

    +0.58%

  • BTI

    0.7150

    48.215

    +1.48%

  • BCC

    0.7900

    91.02

    +0.87%

  • JRI

    0.0200

    13.13

    +0.15%

  • VOD

    0.0100

    9.85

    +0.1%

  • BCE

    -0.0600

    22.445

    -0.27%

  • RYCEF

    0.1000

    12

    +0.83%

  • AZN

    -0.1200

    73.71

    -0.16%

WTO chief hails Covid vaccines IP compromise
WTO chief hails Covid vaccines IP compromise

WTO chief hails Covid vaccines IP compromise

The World Trade Organization chief hailed Wednesday a breakthrough between the EU, the United States, India and South Africa on waiving intellectual property rights on Covid-19 vaccines.

Text size:

Ngozi Okonjo-Iweala said the compromise was a major step forward in a bid to end the logjam at the global trade body.

However, she cautioned that some of the details on waiving WTO rules on Trade-Related Aspects of Intellectual Property Rights (TRIPS) still needed to be fleshed out -- and it would need the backing of all WTO members to come into force.

"This is a major step forward and this compromise is the result of many long and difficult hours of negotiations," Okonjo-Iweala said.

"But we are not there yet. We have more work to do to ensure that we have the support of the entire WTO membership."

Since October 2020, South Africa and India have called for IP rights to be temporarily lifted for coronavirus vaccines during the pandemic in order to boost production and address the gaping inequality in access between rich and poor nations.

However the idea has met with fierce opposition from pharmaceutical giants and most of their host countries.

They have argued that patents are not the main roadblocks to scaling up production and warn the move could hamper innovation.

- 'Wrong solution': pharma lobby -

Okonjo-Iweala stressed that internal domestic consultations were going on in the four parties to the compromise agreement, and some points still needed smoothing out.

But the former Nigerian finance minister said work would start immediately to widen the discussion to all 164 WTO members.

Switzerland, home to several major pharmaceutical companies, has notably repeatedly voiced its unwillingness to budge.

"In the WTO we decide by consensus, and this has not yet been achieved," Okonjo-Iweala said.

"We are ready to roll up our sleeves again to... bring about a full agreement as quickly as possible."

The International Federation of Pharmaceutical Manufacturers and Associations big pharma lobby group slammed the compromise, saying that weakening patents when supply constraints had eased was a mistake.

The IFPMA said 12 billion vaccine doses had been produced within a year of the first jab being authorised, and the industry was now pumping out more than a billion doses per month.

"The challenge now is how to get the vaccines into the arms of people who need them, rather than vaccine supply," the group said.

"The TRIPS waiver is not only the wrong solution, it is also an outdated proposal, that has been overtaken by events."

The IFPMA said the waiver was "unnecessary and irrelevant" and could undermine innovation in response to future pandemics.

- EU 'climbdown' -

Max Lawson, co-chair of the People's Vaccine Alliance coalition campaigning for wider access to Covid vaccines, said the TRIPS waiver proposals did not go far enough.

"After almost 18 months of stalling and millions of deaths, the EU has climbed down and finally admitted that intellectual property rules and pharmaceutical monopolies are a barrier to vaccinating the world," he said.

But Lawson said the proposal was a half-measure and did not address IP rights on Covid-19 treatments.

"Every barrier to accessing these crucial vaccines and treatments must be cleared away," he said.

(A.Berg--BBZ)